AlphaMaven AlphaMaven

Exclusive: Impactive aims to replace WEX CEO on board in proxy fight, sources say

Reported by Reuters ·Wkzo
Apr 10, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Impactive Capital, holding roughly 5% of WEX shares, is urging shareholders to replace three board directors at the May 5 annual meeting, including CEO and Chair Melissa Smith, though the hedge fund is not seeking to remove her from the CEO role itself.
  • • The activist investor is pushing to split WEX's combined CEO and chair positions, citing poor governance and underperformance—WEX's market value has fallen by half since Smith became chair in September 2019, erasing $3.4 billion in shareholder value.
  • • Impactive is addressing regulatory concerns WEX raised last month by signaling in documents that it is not aware of looming regulatory issues that could impede the proxy fight, potentially clearing a significant hurdle for the campaign.
  • • WEX shares have underperformed peers Corpay and HealthEquity as well as the S&P Mid-Cap Index during Smith's tenure as chair, though the stock has recovered 28% over the past 12 months; the company currently has a market capitalization of $5.5 billion.
Summary
Impactive Capital has escalated its board challenge at WEX Inc., urging shareholders to elect three new directors at the company's May 5 annual meeting, according to documents reviewed by Reuters. The activist hedge fund, which owns approximately 5% of WEX's shares, is targeting the removal of CEO and Board Chair Melissa Smith from the board, along with two other sitting directors. Notably, Impactive is not seeking to oust Smith as chief executive officer but rather aims to separate the CEO and chair roles, which remain combined at WEX despite governance best practices increasingly favoring their separation.

Impactive's campaign centers on allegations of persistent underperformance and governance shortcomings under Smith's leadership. The hedge fund contends that WEX's share price has significantly lagged competitors Corpay and HealthEquity, as well as the S&P Mid-Cap Index, since Smith assumed the chair position in September 2019. The financial impact has been substantial: WEX's market value has declined by approximately half during this period, representing a $3.4 billion loss in shareholder value. The hedge fund also challenges Smith's compensation levels as excessive relative to company performance. The company's current market capitalization stands at $5.5 billion, and its share price has appreciated 28% over the past 12 months.

In a strategic move to mitigate potential obstacles, Impactive has addressed regulatory concerns that WEX raised in the prior month by asserting in its proxy documents that it is not aware of any looming regulatory impediments to the proxy fight. This statement represents an attempt to preempt a critical line of defense that WEX might employ to block or delay the activist campaign. WEX operates across three primary business segments: fleet management, corporate payments, and employee benefits services. The shareholder vote is scheduled for May 5.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

2 outlets

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Reuters Exclusive: Impactive aims to replace WEX CEO on board in proxy fight, sources say Wkzo Exclusive-Impactive aims to replace WEX CEO on board in proxy fight, sources say